Table 2 Demographic and clinical characteristics of the TRS groups with and without admission
Variables | TRS with admission for FEP (n = 41) | TRS without admission for FEP (n = 38) | Statistic Values |
|---|---|---|---|
General information | |||
Age (years) | 41.6 [10.2] | 42.1 [12.1] | t = −0.197, P = 0.844 |
Sex: Male/Female (n) | 26/15 | 21/17 | Chi = 0.544, P = 0.461 |
Follow-up duration (days) | 6040.2 [3424.8] | 6247.1 [4005.1] | t = −0.247, P = 0.805 |
Age at onset (years) | 24.1 [7.5] | 23.9 [9.2] | t = 0.122, P = 0.903 |
Duration before meeting TRS (days) | 2538.9 [2640.0] | 3885.9 [3511.6] | t = −1.994, P = 0.050 |
Clinical index prior to treatment introduction | |||
Premorbid social adjustment | 4.27 [3.29] | 5.18 [2.95] | t = −1.298, P = 0.198 |
DUP (months) | 8.69 [17.6] | 10.67 [15.39] | t = 0.512, |
DUP Median | 2.00 | 6.00 | P = 0.610 |
Mode of onset: Acute/Insidious (n) | 27/14 | 14/24 | Chi = 6.65, P = 0.010 |
Clinical index related to FEP | |||
Duration of initial hospital admission (days) | 169.3 [261.4] | 0 [0] | t = 3.992, P < 0.001 |
GAF after FEP | 53.2 [16.8] | 46.8 [16.0] | t = 1.716, P = 0.090 |
GAF > 70 (n) | 8 | 3 | – |
CP-dose for FEP treatment (mg) | 654.4 [427.5] | 467.9 [374.6] | t = 2.034, P = 0.046 |